Stonepine Capital Management’s Gamida Cell GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-7,965,865
Closed -$8.2M – 23
2023
Q3
$8.2M Buy
7,965,865
+6,465,865
+431% +$8.26M 2.73% 9
2023
Q2
$2.9M Buy
+1,500,000
New +$2.58M 1.04% 17
2021
Q4
– Sell
-1,724,201
Closed -$6.76M – 35
2021
Q3
$6.76M Buy
1,724,201
+1,280,694
+289% +$6.4M 3.08% 10
2021
Q2
$2.84M Buy
443,507
+198,992
+81% +$1.37M 1.49% 17
2021
Q1
$1.98M Sell
244,515
-134,955
-36% -$1.24M 1.07% 20
2020
Q4
$3.18M Buy
+379,470
New +$2.57M 2.44% 13

Other funds holding GMDA

Stonepine Capital Management's GMDA Position: Q4 2023 in Review

Stonepine Capital Management sold out of Gamida Cell (GMDA) in Q4 2023, closing a stake of 7,965,865 shares — an estimated $8.2M sold.

Stonepine Capital Management first reported a position in GMDA in Q4 2020 and held it in 6 quarters. The position peaked at $8.2M in Q3 2023. 52 funds tracked by Wall St. Rank hold GMDA as of Q4 2023.

  • Stonepine Capital Management reported no remaining Gamida Cell position as of Q4 2023 after selling out during the quarter.
  • Stonepine Capital Management sold 7,965,865 Gamida Cell shares in Q4 2023, an estimated $8.2M.
  • Stonepine Capital Management first reported a position in Gamida Cell in Q4 2020 and held it in 6 quarters.
  • Stonepine Capital Management's Gamida Cell position peaked at $8.2M in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Gamida Cell as of Q4 2023.

Based on Stonepine Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.